Purification of human galectin-1 produced in high-cell density cultures of recombinant Escherichia coli: a comparison with classic shake flask cultivation

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Didier LutomskiRaymonde Joubert-Caron

Abstract

The aim of the present work was to develop a highly productive and simplified process for active human galectin-1 (Gal1) production. Gal1 is a beta-galactoside binding lectin that differentially affects biological and cellular functions such as immune surveillance and apoptosis. These effects have attracted the attention of researchers in cell biology, biochemistry and immunology. However, the production of sufficient amounts of recombinant human Gal1 (rhGal1) is needed to study of the effects of Gal1 during cell treatments. To this end, an high-yield expression of rhGal1 was achieved by high-cell density fed-batch cultivation using an exponential glycerol feeding strategy and rhGal1 was purified by a one-step purification scheme using affinity chromatography.

References

Feb 21, 1995·Journal of Biotechnology·D J KorzW D Deckwer
Mar 1, 1996·Trends in Biotechnology·S Y Lee
Apr 17, 1998·Journal of Chromatography. B, Biomedical Sciences and Applications·M FouillitR Joubert-Caron
May 26, 1999·Applied Microbiology and Biotechnology·D Riesenberg, R Guthke
Dec 2, 1999·Biochimica Et Biophysica Acta·R C Hughes
Apr 6, 2001·Rapid Communications in Mass Spectrometry : RCM·E GustafssonC L Nilsson
Jun 22, 2002·Acta Crystallographica. Section D, Biological Crystallography·Gabriel DavidAnita Lewit-Bentley
Nov 27, 2002·Biotechnology and Bioengineering·Anna Maria SandénGen Larsson
Jan 1, 1991·Neurochemistry International·D BladierJ Rossier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis